Rocket’s Gene Therapy Trial Paused, Boltz-2 Open Source, Plasma Swap Rewinds Aging
This week’s episode covers a wide range of topics from open-source AI to clinical trials to increasing longevity.
Related Articles
America is ceding the lead in creating the future
The renowned American management consultant and author Peter Drucker is often credited as saying that “the best way to predict the future is to create…
Biomanufacturing Gains as Lab Leasing Lags
The JLL report highlights a clear preference among tenants for high-quality Class A space in prime locations.
Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr-deficient mice
Hepatic inflammation-targeting pemafibrate reduces atherosclerosis in Ldlr−/− mice, supporting a role for inflammation in cardiovascular risk.
World’s largest organism found in Australia
Single hybrid seagrass plant now stretches across 180 kilometers
How AI is Accelerating the Scientific Method from Trial and Error to Targeted Discovery
AI will greatly lessen the effort of the discovery process, bringing more novel therapies to the forefront faster than ever before.
Farming maize in ice age Michigan, predicting the future climate of cities, and our host takes a quiz on the sounds of science
Main content starts here Home Podcasts Farming maize in ice age Michigan, predicting the future climate of cities, and our host takes a quiz on…
Shedding Light on AMR Superbugs: From Penicillin to Photoactivated Precision
Photopharmacology combats antimicrobial resistance by enabling precise, light-triggered activation of penicillin at infection sites.
Addressing cancer patients’ barriers to care with an online platform
Rahul Mahadevan, founder and CEO of WiTT Group, discusses the company’s platform, which empowers patients to reach out for their non-clinical needs and gives health…
Cancer patients find community support online
Rahul Mahadevan founded WiTT Group to create a platform where patients can ask for help with specific needs after he saw other patients delaying or…
Nociceptor-specific signaling of the receptor guanylyl cyclase Npr2 contributes to acute and persistent pain
The pain-sensing pathway in sensory neurons involving cGMP production by Npr2 is revealed.